Pancreatic Cancer
📧 Sign up to get email alerts when something new happens for Pancreatic Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2024-12-09Clinical Trial Update: Study of Adjuvant Nimotuzumab Combined with Nab-paclitaxel+ Gemcitabine in EGFR-positive Pancreatic Cancer [Phase 2]
Phase 2 adjuvant trial evaluating nimotuzumab with nab-paclitaxel and gemcitabine in EGFR-positive resectable pancreatic cancer. The study i…
-
CLINICAL_TRIALS research · 2024-12-06Clinical Trial Update: Cell-Free DNA Chromatin Immunoprecipitation (ChIP) for Diagnosing Cancer
A study evaluating a cell-free DNA chromatin immunoprecipitation method to diagnose cancer, with pancreatic cancer as the condition, is curr…
-
CLINICAL_TRIALS research · 2024-12-06Clinical Trial Update: Microbiota and Pancreatic Cancer Cachexia
A clinical trial is examining the relationship between the gut microbiota and pancreatic cancer cachexia, with recruitment currently ongoing…
-
CLINICAL_TRIALS research · 2024-12-05Clinical Trial Update: An Artificial Intelligence System for ROSE of EUS-FNA Sample: a Prospective, Multicenter, Diagnostic Study.
This clinical trial update describes a prospective multicenter study evaluating an AI-assisted ROSE system for EUS-FNA samples to diagnose m…
-
CLINICAL_TRIALS research · 2024-12-03Clinical Trial Update: Standard or Prolonged Neoadjuvant Chemotherapy Before Surgery for BR/LAPC [Phase 3]
Phase 3 clinical trial comparing standard versus prolonged neoadjuvant chemotherapy before surgery for locally advanced or borderline resect…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2024-12-03Clinical Trial Update: Observational Copenhagen Pancreatic Cancer Study
An observational study in Copenhagen is investigating pancreatic cancer; the trial is not yet recruiting.
-
CLINICAL_TRIALS research · 2024-12-03Clinical Trial Update: Exercise to Boost Immunity in Advanced Cancer [NA]
A clinical trial is evaluating whether an exercise program can boost immune response in patients with malignant mesothelioma, lung cancer, o…
-
CLINICAL_TRIALS research · 2024-12-02Clinical Trial Update: Spanish Registry of Digestive Tumours RETUD
This entry notes the RETUD Spanish registry for digestive tumours is currently recruiting, sponsored by the Spanish Cooperative Group for th…
-
CLINICAL_TRIALS research · 2024-11-27Clinical Trial Update: NeoFOL-R Trial (Perioperative Versus Adjuvnat FOLFIRINOX in Resectable Pancreatic Cancer) [Phase 3]
Clinical trial update for NeoFOL-R, a Phase 3 study comparing perioperative versus adjuvant FOLFIRINOX in resectable pancreatic cancer; curr…
-
CLINICAL_TRIALS research · 2024-11-26Clinical Trial Update: Vitamin C Plus Cordyceps to Chemotherapy Related Anemia in Pancreatic Cancer [Phase 2, Phase 3]
A Phase 2/Phase 3 clinical trial from Fudan University is evaluating Vitamin C plus Cordyceps to address chemotherapy-related anemia in panc…
-
CLINICAL_TRIALS research · 2024-11-26Clinical Trial Update: Vitamin C Plus Cordyceps to Quality of Life in Patients With Terminal Stage Pancreatic Cancer [Phase 2, Phase 3]
An ongoing study from Fudan University is evaluating whether adding Vitamin C and Cordyceps to standard care can improve quality of life in …
-
CLINICAL_TRIALS research · 2024-11-25Clinical Trial Update: Conventional Partial Pancreatoduodenectomy Versus an Extended Pancreatoduodenectomy for Pancreatic Head Cancers [NA]
A clinical trial investigating conventional partial pancreatoduodenectomy versus extended pancreatoduodenectomy for resectable pancreatic he…
-
CLINICAL_TRIALS research · 2024-11-22Clinical Trial Update: Second-line Irinotecan Liposome Combination Regimen for Irinotecan-treated Pancreatic Cancer [Phase 2]
A Phase 2 trial is evaluating a second-line regimen that includes liposomal irinotecan for patients with pancreatic cancer previously treate…
-
CLINICAL_TRIALS research · 2024-11-20Clinical Trial Update: Evaluation of Outcomes from Treatment of Benign or Malignant Gastroesophageal Diseases
A recruiting clinical trial sponsored by Methodist Health System is evaluating outcomes from treatments for pancreatic cancer.
-
CLINICAL_TRIALS research · 2024-11-20Clinical Trial Update: Nordic Pancreatic Cancer Trial (NorPACT) - 1 [Phase 2, Phase 3]
Clinical trial update for the Nordic Pancreatic Cancer Trial (NorPACT), a Phase 2/3 study sponsored by Oslo University Hospital, currently a…
-
CLINICAL_TRIALS research · 2024-11-15Clinical Trial Update: Conversion Surgery Vs. Palliative Care in Pancreatic Cancer Oligometastatic to the Liver [Phase 2]
A Phase 2 clinical trial compares conversion surgery to palliative care for pancreatic cancer with liver oligometastases and is currently re…
-
CLINICAL_TRIALS research · 2024-11-14Clinical Trial Update: A Multi-center, Single-arm, Prospective Non-interventional Study to Investigate the Safety Profiles and Effectiveness of Liposomal Irinotecan (ONIVYDE®) in Combination with 5-fluorouracil (5-FU) and Leucovorin (LV) in Chinese Patients with Metastatic Pancreatic Cancer As Approval Condition (SEOPAC)
This is a multi-center, single-arm, prospective non-interventional study to evaluate the safety and effectiveness of liposomal irinotecan (O…
-
CLINICAL_TRIALS research · 2024-11-07Clinical Trial Update: Irreversible Electroporation Ablation Combined With Anti-PD(L)1 Therapy for Locally Advanced Pancreatic Cancer
This clinical trial evaluates irreversible electroporation ablation combined with anti-PD-L1 therapy for locally advanced pancreatic cancer;…
-
CLINICAL_TRIALS research · 2024-11-01Clinical Trial Update: NALIRIFOX Combined With PD-1 Sequential Radiotherapy Versus NALIRIFOX as Conversion Therapy of Locally Advanced Pancreatic Cancer [Phase 2]
A Phase 2 clinical trial update evaluating NALIRIFOX combined with a PD-1 inhibitor and sequential radiotherapy versus NALIRIFOX alone as co…
-
CLINICAL_TRIALS research · 2024-10-31Clinical Trial Update: Nimotuzumab Combined With mFOLFIRINOX/GX as Postoperative Adjuvant Therapy in Pancreatic Cancer [Phase 2]
A Phase 2 clinical trial evaluating nimotuzumab in combination with modified FOLFIRINOX/GX as postoperative adjuvant therapy for pancreatic …
-
CLINICAL_TRIALS research · 2024-10-29Clinical Trial Update: YL-13027 and/or HY-0102 Combined With AG Regimen Chemotherapy for Metastatic Pancreatic Cancer [Phase 1, Phase 2]
This clinical trial update describes a Phase 1/2 study evaluating YL-13027 and HY-0102 in combination with AG regimen chemotherapy for metas…
-
CLINICAL_TRIALS research · 2024-10-26Clinical Trial Update: Preoperative Optimisation of Modifiable Risk Factors in Surgery of the Pancreas [NA]
This entry reports a clinical trial assessing preoperative optimization of modifiable risk factors to reduce postoperative complications in …
-
CLINICAL_TRIALS research · 2024-10-26Clinical Trial Update: Fecal and Oral Microbiota Between Pancreatic Cancer and Benign/Low-grade Malignant Tumor Patients
A completed clinical trial comparing fecal and oral microbiota profiles between pancreatic cancer patients and those with benign or low-grad…
-
CLINICAL_TRIALS research · 2024-10-23Clinical Trial Update: Profiling the Intratumoral Microbiome of Pancreatic Ductal Adenocarcinoma Based on EUS-FNB Tissue Samples and Exploring Its Impact on Tumor Diagnosis and Prognosis.
This clinical trial is profiling the intratumoral microbiome of pancreatic ductal adenocarcinoma using EUS-FNB tissue and exploring how micr…
-
CLINICAL_TRIALS research · 2024-10-22Clinical Trial Update: First in Human Study of TORL-2-307-MAB in Participants With Advanced Cancer [Phase 1]
First-in-human Phase 1 trial of TORL-2-307-MAB in participants with advanced cancer, including gastric cancer, pancreatic cancer, and gastro…